JPWO2023023255A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2023023255A5 JPWO2023023255A5 JP2024508943A JP2024508943A JPWO2023023255A5 JP WO2023023255 A5 JPWO2023023255 A5 JP WO2023023255A5 JP 2024508943 A JP2024508943 A JP 2024508943A JP 2024508943 A JP2024508943 A JP 2024508943A JP WO2023023255 A5 JPWO2023023255 A5 JP WO2023023255A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- optionally substituted
- pharmaceutical composition
- disease
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025022773A JP7820584B2 (ja) | 2021-08-18 | 2025-02-14 | インターロイキン－１受容体関連キナーゼの二官能性分解剤及びその治療的使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163234606P | 2021-08-18 | 2021-08-18 | |
| US63/234,606 | 2021-08-18 | ||
| PCT/US2022/040765 WO2023023255A1 (en) | 2021-08-18 | 2022-08-18 | Bifunctional degraders of interleukin-1 receptor-associated kinases and therapeutic use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025022773A Division JP7820584B2 (ja) | 2021-08-18 | 2025-02-14 | インターロイキン－１受容体関連キナーゼの二官能性分解剤及びその治療的使用 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2024531273A JP2024531273A (ja) | 2024-08-29 |
| JP2024531273A5 JP2024531273A5 (https=) | 2025-02-25 |
| JPWO2023023255A5 true JPWO2023023255A5 (https=) | 2025-02-25 |
| JP7774709B2 JP7774709B2 (ja) | 2025-11-21 |
Family
ID=83594510
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024508943A Active JP7774709B2 (ja) | 2021-08-18 | 2022-08-18 | インターロイキン－１受容体関連キナーゼの二官能性分解剤及びその治療的使用 |
| JP2025022773A Active JP7820584B2 (ja) | 2021-08-18 | 2025-02-14 | インターロイキン－１受容体関連キナーゼの二官能性分解剤及びその治療的使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025022773A Active JP7820584B2 (ja) | 2021-08-18 | 2025-02-14 | インターロイキン－１受容体関連キナーゼの二官能性分解剤及びその治療的使用 |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US11976071B2 (https=) |
| EP (2) | EP4512402A3 (https=) |
| JP (2) | JP7774709B2 (https=) |
| KR (1) | KR20240048010A (https=) |
| CN (1) | CN117813307A (https=) |
| AR (1) | AR126826A1 (https=) |
| AU (2) | AU2022330009B2 (https=) |
| CA (1) | CA3226118A1 (https=) |
| CL (1) | CL2024000446A1 (https=) |
| CO (1) | CO2024001524A2 (https=) |
| CR (1) | CR20240080A (https=) |
| DK (1) | DK4367118T3 (https=) |
| DO (1) | DOP2024000028A (https=) |
| ES (1) | ES3024057T3 (https=) |
| FI (1) | FI4367118T3 (https=) |
| HR (1) | HRP20250402T1 (https=) |
| HU (1) | HUE070709T2 (https=) |
| IL (1) | IL310446A (https=) |
| LT (1) | LT4367118T (https=) |
| MX (1) | MX2024002153A (https=) |
| PE (1) | PE20241618A1 (https=) |
| PL (1) | PL4367118T3 (https=) |
| PT (1) | PT4367118T (https=) |
| SI (1) | SI4367118T1 (https=) |
| TW (2) | TW202535879A (https=) |
| WO (1) | WO2023023255A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021026517A2 (pt) | 2019-06-28 | 2022-05-10 | Kymera Therapeutics Inc | Degradadores de irak e usos dos mesmos |
| WO2021011868A1 (en) | 2019-07-17 | 2021-01-21 | Kymera Therapeutics, Inc. | Irak degraders and uses thereof |
| US12551564B2 (en) | 2019-12-10 | 2026-02-17 | Kymera Therapeutics, Inc. | IRAK degraders and uses thereof |
| WO2021127190A1 (en) | 2019-12-17 | 2021-06-24 | Kymera Therapeutics, Inc. | Irak degraders and uses thereof |
| EP4107158A1 (en) | 2020-02-19 | 2022-12-28 | Nurix Therapeutics, Inc. | Bifunctional degraders of interleukin-1 receptor-associated kinases and therapeutic use thereof |
| US20240208923A1 (en) | 2021-03-10 | 2024-06-27 | Jnana Therapeutics Inc. | Small molecule inhibitors of mammalian slc6a19 function |
| FI4367118T3 (fi) | 2021-08-18 | 2025-04-09 | Nurix Therapeutics Inc | Interleukiini-1-reseptoriin liittyvien kinaasien bifunktionaalisia hajotusaineita ja niiden terapeuttinen käyttö |
| WO2023186069A1 (zh) * | 2022-03-31 | 2023-10-05 | 石药集团中奇制药技术（石家庄）有限公司 | 一类白介素-1受体相关激酶4的双功能嵌合体杂环化合物及其制备方法、药用组合物和用途 |
| KR20260022390A (ko) | 2023-06-08 | 2026-02-19 | 누릭스 테라퓨틱스 인코포레이티드 | Smarca2의 선택적 분해제로서의 이작용성 아진 접합체 및 이의 치료적 용도 |
| WO2025149070A1 (zh) * | 2024-01-10 | 2025-07-17 | 甘李药业股份有限公司 | 一种新型靶向白细胞介素1受体关联激酶4(irak4)的蛋白降解嵌合体化合物的合成及其应用 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6306663B1 (en) | 1999-02-12 | 2001-10-23 | Proteinex, Inc. | Controlling protein levels in eucaryotic organisms |
| US7208157B2 (en) | 2000-09-08 | 2007-04-24 | California Institute Of Technology | Proteolysis targeting chimeric pharmaceutical |
| US7041298B2 (en) | 2000-09-08 | 2006-05-09 | California Institute Of Technology | Proteolysis targeting chimeric pharmaceutical |
| US7030112B2 (en) | 2003-03-25 | 2006-04-18 | Bristol-Myers Squibb Company | Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders |
| CA2663091A1 (en) | 2006-09-07 | 2008-03-13 | Biogen Idec Ma Inc. | Modulators of interleukin-1 receptor-associated kinase |
| US9464326B2 (en) | 2012-03-22 | 2016-10-11 | University Of Maryland, Baltimore | Total and phosphorylated IL-1 receptor-associated kinase-1 and IL-1 receptor-associated kinase-4 as a biomarker for cancer progression and chemotherapy resistance |
| TW201609693A (zh) | 2014-01-03 | 2016-03-16 | 必治妥美雅史谷比公司 | 雜芳基取代之菸鹼醯胺化合物 |
| AU2015247817C1 (en) | 2014-04-14 | 2022-02-10 | Arvinas Operations, Inc. | Imide-based modulators of proteolysis and associated methods of use |
| JP6815318B2 (ja) | 2014-12-23 | 2021-01-20 | ダナ−ファーバー キャンサー インスティテュート，インコーポレイテッド | 二官能性分子によって標的化タンパク質分解を誘導する方法 |
| TW201718571A (zh) | 2015-06-24 | 2017-06-01 | 必治妥美雅史谷比公司 | 經雜芳基取代之胺基吡啶化合物 |
| ES2822956T3 (es) | 2015-06-24 | 2021-05-05 | Bristol Myers Squibb Co | Compuestos de aminopiridina sustituidos con heteroarilo |
| US10487329B2 (en) | 2015-10-29 | 2019-11-26 | Children's Hospital Medical Center | Methods and compositions for the treatment of head and neck cancer |
| CN109641874A (zh) | 2016-05-10 | 2019-04-16 | C4医药公司 | 用于靶蛋白降解的c3-碳连接的戊二酰亚胺降解决定子体 |
| WO2018071606A1 (en) | 2016-10-11 | 2018-04-19 | Arvinas, Inc. | Compounds and methods for the targeted degradation of androgen receptor |
| EP3532164A4 (en) | 2016-10-28 | 2020-10-07 | Children's Hospital Medical Center | TREATMENT OF IRAQ ASSOCIATED DISEASES ACTIVATED |
| BR112019015484A2 (pt) | 2017-01-31 | 2020-04-28 | Arvinas Operations Inc | ligantes de cereblon e compostos bifuncionais compreendendo os mesmos |
| TW202340194A (zh) | 2017-02-16 | 2023-10-16 | 美商基利科學股份有限公司 | 吡咯并[1,2-b]嗒𠯤衍生物 |
| WO2018232288A1 (en) | 2017-06-16 | 2018-12-20 | Genentech, Inc. | Diagnostic and therapeutic methods for irak4-mediated disorders and conditions |
| US11065231B2 (en) | 2017-11-17 | 2021-07-20 | Arvinas Operations, Inc. | Compounds and methods for the targeted degradation of interleukin-1 receptor- associated kinase 4 polypeptides |
| WO2019103196A1 (ko) | 2017-11-24 | 2019-05-31 | 엘지전자 주식회사 | 무선 통신 시스템에서 빔을 리포팅하는 방법 및 장치 |
| IL315310A (en) | 2017-12-26 | 2024-10-01 | Kymera Therapeutics Inc | Irak degraders and uses thereof |
| WO2019160915A1 (en) | 2018-02-14 | 2019-08-22 | Dana-Farber Cancer Institute, Inc. | Irak degraders and uses thereof |
| TWI842978B (zh) | 2018-07-13 | 2024-05-21 | 美商基利科學股份有限公司 | 衍生物 |
| US20200038513A1 (en) | 2018-07-26 | 2020-02-06 | Arvinas Operations, Inc. | Modulators of fak proteolysis and associated methods of use |
| WO2020036830A1 (en) | 2018-08-13 | 2020-02-20 | Gilead Sciences, Inc. | Pyrrolo[1,2-b]pyridazine derivatives as irak4 inhibitors |
| TWI727392B (zh) | 2018-08-13 | 2021-05-11 | 美商基利科學股份有限公司 | 噻二唑irak4抑制劑 |
| WO2021011868A1 (en) | 2019-07-17 | 2021-01-21 | Kymera Therapeutics, Inc. | Irak degraders and uses thereof |
| EP4038066A1 (en) | 2019-10-01 | 2022-08-10 | Arvinas Operations, Inc. | Brm targeting compounds and associated methods of use |
| US11820781B2 (en) * | 2019-12-04 | 2023-11-21 | Nurix Therapeutics, Inc. | Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway |
| EP4107158A1 (en) * | 2020-02-19 | 2022-12-28 | Nurix Therapeutics, Inc. | Bifunctional degraders of interleukin-1 receptor-associated kinases and therapeutic use thereof |
| WO2021180103A1 (en) | 2020-03-11 | 2021-09-16 | Beigene, Ltd. | Degradation of bruton's tyrosine kinase (btk) by conjugation of btk inhibitors with e3 ligase ligand and methods of use |
| MX2022016061A (es) | 2020-06-17 | 2023-02-02 | Kymera Therapeutics Inc | Degradadores de cinasa asociada al receptor interleucina-1 (irak) y usos de los mismos. |
| WO2021255212A1 (en) | 2020-06-19 | 2021-12-23 | F. Hoffmann-La Roche Ag | Braf degraders |
| US20240208923A1 (en) | 2021-03-10 | 2024-06-27 | Jnana Therapeutics Inc. | Small molecule inhibitors of mammalian slc6a19 function |
| CA3217892A1 (en) | 2021-05-03 | 2022-11-10 | Joel Mcintosh | Compounds for inhibiting or degrading target proteins, compositions, comprising the same, methods of their making, and methods of their use |
| US12018016B2 (en) | 2021-08-18 | 2024-06-25 | Amgen Inc. | Aryl sulfonyl (hydroxy) piperidines as CCR6 inhibitors |
| FI4367118T3 (fi) | 2021-08-18 | 2025-04-09 | Nurix Therapeutics Inc | Interleukiini-1-reseptoriin liittyvien kinaasien bifunktionaalisia hajotusaineita ja niiden terapeuttinen käyttö |
| TW202321229A (zh) | 2021-08-18 | 2023-06-01 | 美商富曼西公司 | 殺真菌的取代的雜環化合物 |
-
2022
- 2022-08-18 FI FIEP22785813.1T patent/FI4367118T3/fi active
- 2022-08-18 PL PL22785813.1T patent/PL4367118T3/pl unknown
- 2022-08-18 CN CN202280056402.6A patent/CN117813307A/zh active Pending
- 2022-08-18 TW TW114118091A patent/TW202535879A/zh unknown
- 2022-08-18 ES ES22785813T patent/ES3024057T3/es active Active
- 2022-08-18 JP JP2024508943A patent/JP7774709B2/ja active Active
- 2022-08-18 LT LTEPPCT/US2022/040765T patent/LT4367118T/lt unknown
- 2022-08-18 AR ARP220102235A patent/AR126826A1/es unknown
- 2022-08-18 EP EP25150164.9A patent/EP4512402A3/en active Pending
- 2022-08-18 US US17/820,770 patent/US11976071B2/en active Active
- 2022-08-18 CA CA3226118A patent/CA3226118A1/en active Pending
- 2022-08-18 KR KR1020247008466A patent/KR20240048010A/ko active Pending
- 2022-08-18 HU HUE22785813A patent/HUE070709T2/hu unknown
- 2022-08-18 EP EP22785813.1A patent/EP4367118B1/en active Active
- 2022-08-18 IL IL310446A patent/IL310446A/en unknown
- 2022-08-18 CR CR20240080A patent/CR20240080A/es unknown
- 2022-08-18 PE PE2024000254A patent/PE20241618A1/es unknown
- 2022-08-18 SI SI202230111T patent/SI4367118T1/sl unknown
- 2022-08-18 WO PCT/US2022/040765 patent/WO2023023255A1/en not_active Ceased
- 2022-08-18 AU AU2022330009A patent/AU2022330009B2/en active Active
- 2022-08-18 MX MX2024002153A patent/MX2024002153A/es unknown
- 2022-08-18 PT PT227858131T patent/PT4367118T/pt unknown
- 2022-08-18 TW TW111131116A patent/TWI886406B/zh active
- 2022-08-18 DK DK22785813.1T patent/DK4367118T3/da active
- 2022-08-18 HR HRP20250402TT patent/HRP20250402T1/hr unknown
-
2024
- 2024-02-14 CL CL2024000446A patent/CL2024000446A1/es unknown
- 2024-02-14 DO DO2024000028A patent/DOP2024000028A/es unknown
- 2024-02-14 CO CONC2024/0001524A patent/CO2024001524A2/es unknown
- 2024-04-01 US US18/623,738 patent/US12570662B2/en active Active
-
2025
- 2025-02-14 JP JP2025022773A patent/JP7820584B2/ja active Active
- 2025-09-23 AU AU2025234314A patent/AU2025234314A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69331892T2 (de) | Desoxy-Taxol-Derivate | |
| JPWO2023023255A5 (https=) | ||
| ES2717306T3 (es) | Derivados de piperidinona como inhibidores de MDM2 para el tratamiento de cáncer | |
| EP2760845B1 (en) | Heterocyclic compounds as mdm2 inhibitors for the treatment of cancer | |
| BE1024380B1 (fr) | Phospholipidation d'imidazoquinoleines et d'oxoadenines | |
| JP2009500347A5 (https=) | ||
| JP5485140B2 (ja) | ５−メチルウリジンを出発原料とするエチニルチミジン化合物の製造方法 | |
| KR102863667B1 (ko) | (2-아세트아미딜)티오-베타-d-갈락토피라노시드 유도체 | |
| BR112020004126A2 (pt) | conjugado anticorpo-derivado de pirrolbenzodiazepina | |
| JP2018528275A (ja) | Ｉｌ−１７の阻害及び他の使用のためのｃ４修飾オレアノール酸誘導体 | |
| JPWO2021168197A5 (https=) | ||
| JP2025143290A (ja) | Ｎｌｒｐ３モジュレーターとしてのスルホンイミドアミド化合物 | |
| AU2021324901A1 (en) | Compounds, compositions and methods | |
| JP2013537905A (ja) | Ｃ型肝炎ウイルス阻害剤 | |
| JPH0193562A (ja) | スフィンゴシン誘導体 | |
| ES2704951T3 (es) | Compuesto precursor de marcaje radioactivo y método para producir un compuesto marcado con flúor radioactivo utilizando el compuesto precursor | |
| KR20230083301A (ko) | 알파-d-갈락토피라노사이드의 스피로 유도체 | |
| JP2009511599A5 (https=) | ||
| CN1151795C (zh) | 含(磺基吡喃糖基)酰基甘油衍生物的药品 | |
| JPWO2019216433A1 (ja) | オリゴ核酸化合物の製造方法 | |
| BR112020016784A2 (pt) | Composto de di-hidropirimidinona ou di-hidropirimidinona condensado ao anel saturado e uso farmacêutico do mesmo | |
| US20240254132A1 (en) | Compounds, compositions and methods | |
| US20250197399A1 (en) | Compounds, compositions, and methods | |
| HK1046690B (zh) | 核糖取代的新芳族酰胺、其制备方法及其作为药剂的用途 | |
| JP6351107B2 (ja) | チオラン骨格型糖化合物の製造方法およびチオラン骨格型糖化合物 |